- Home
- /
- Treatment
- /
- Page 62
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Combination of nivolumab and ipilimumab | Metastatic Melanoma | Bristol-Myers Squibb Company;5 Research Parkway;Wallingford, Connecticut, 06492 | October 9, 2014 | |
S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide) | Hemoglobinuria | Amyndas Pharmaceuticals;N.Zerva 28;Glyfada | October 9, 2014 | |
A-dmDT390-bisFv(UCHT1) | Cutaneous T-cell lymphoma | Angimmune, LLC;American Red Cross Holland Laboratory, 15601 Crabbs Branch Way;Rockville, Maryland, 20855 | October 9, 2014 | |
Adeno-associated viral vector serotype 9 containing the human cardiac calsequestrin gene | Polymorphic Catecholergic Ventricular Tachycardia | Audentes Therapeutics, Inc.;101 Montgomery St., #2650;San Francisco, California, 94104 | October 2, 2014 | |
Inhibitor of primary and secondary KIT and PDGFR alpha kinase mutants found in GIST | Gastrointestinal Stromal Tumors | Deciphera Pharmaceuticals, LLC;643 Massachusetts, Suite 200;Lawrence, Kansas, 66044 | October 2, 2014 | |
Theranost 68 Ga RGD | A Diagnostic for the management of Moyamoya disease (MMD) | Advanced Imaging Projects, LLC (AIP);3651 FAU Blvd.;Boca Raton, Florida, 33467 | October 1, 2014 | |
PEGylated recombinant human hyaluronidase PH20 | Pancreatic Cancer | Halozyme Therapeutics, Inc.;11388 Sorrento Valley Road;San Diego, California, 92121 | October 1, 2014 | |
Adenovirus delta 24-RGD, an oncolytic adenovirus genetically modified for treatment of glioma | Glioma | DNAtrix, Inc.;3210 Merryfield Row;San Diego, California, 92121 | October 1, 2014 | |
Adeno-associated virus serotype 9 expressing the human Survival Motor Neuron gene | Spinal muscular atrophy | AveXis, Inc.;One Energy Square, Suite 604;Dallas, Texas, 75206 | September 30, 2014 | |
Aldoxorubicin | Small cell lung cancer | NantCell, Inc.;9920 Jefferson Boulevard;Culver City, California, 90232 | September 24, 2014 | |
Aldoxorubicin | Glioblastoma | NantCell, Inc.;9920 Jefferson Boulevard;Culver City, California, 90232 | September 24, 2014 | |
Aldoxorubicin | Ovarian cancer | NantCell, Inc.;9920 Jefferson Boulevard;Culver City, California, 90232 | September 24, 2014 | |
Cannabidiol | Glioma | Insys Development Company, Inc.;1333 S. Spectrum Blvd, Suite 100;Chandler, Arizona, 85286 | September 24, 2014 | |
68G-OPS202, small somatostatin analog labeled with 68Gallium | Management of gastroenteropancreatic neuroendocrine tumors | Ipsen Biosciences, Inc.;650 East Kendall Street;Cambridge, Massachusetts, 02142 | September 24, 2014 | |
MV-NB-02, its bivalent ganglioside vaccine consisting of GD2-lactone and GD3-lactone each covalently conjugated to keyhole hemocyanin | Neuroblastoma | MabVax Therapeutics, Inc.;11588 Sorrento Road, Suite 20;San Diego, California, 92121 | September 23, 2014 | |
4-amino-1-[(1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl) cyclopent-2-en-1-yl] pyrimidin-2-one | Pancreatic cancer | Rexahn Pharmaceuticals, Inc.;15245 Shady Grove Road;Rockville, Maryland, 20850 | September 23, 2014 | |
Single chain urokinase plasminogen activator | Empyema (pleural) | Lung Therapeutics, Inc.;P. O. Box 150183;Austin, Texas, 78715 | September 11, 2014 | |
(3S)-1-azabicyclo[2.2.2]oct-3-yl {2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl}carbamate | Gaucher disease | Genzyme;500 Kendall Street;Cambridge, Massachusetts, 02142 | September 11, 2014 | |
Cysteamine | Cystic fibrosis | NovaBiotics Ltd.;Cruickshank Building, Craibstone;Aberdeen AB21 9TR | September 11, 2014 | |
Vemurafenib | Non-small cell lung cancer | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 | September 8, 2014 | |
5,7-dichloro-2-dimethylaminomethyl-8-hydroxyquinoline hydrochloride | Huntington disease | Prana Biotechnology Limited;Level 2, 369 Royal Parade, Parkville;Victoria 3052 | September 4, 2014 | |
6-((3S,4S)-4-Methyl-1-pyrimidin-2-ylmethyl-pyrrolidin-3-yl-1-(tetrahydro-pyran-4-yl)-1,5-dihydro-pryazolo[3,4-d]pyrimidin-4-one | Sickle cell anemia | Pfizer, Inc.;500 Arcola Road;Collegeville, Pennsylvania, 19426 | September 4, 2014 | |
N-(2-{2-dimethylaminoethyl-methylamino}-4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide mesylate salt | Epidermal growth factor receptor mutation-positive non-small cell lung cancer | AstraZeneca Pharmaceuticals LP;P. O. Box 8355, 1800 Concord Pike;Wilmington, DE, 19803-8355 | September 4, 2014 | |
Osimertinib | Non-small cell lung cancer | AstraZeneca Pharmaceuticals LP;P. O. Box 8355, 1800 Concord Pike;Wilmington, Delaware, 19803 | September 4, 2014 | |
5,7-dichloro-2-methylaminomethyl-8-hydroxyquinolone hydrochloride | Huntington disease | Prana Biotechnology Limited;Level 2, 369 Royal Parade, Parkville;Victoria 3052 | September 4, 2014 |